SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-10-044431
Filing Date
2010-08-30
Accepted
2010-08-30 16:42:45
Documents
1
Period of Report
2010-08-20

Document Format Files

Seq Description Document Type Size
1 MAIN DOCUMENT DESCRIPTION c05448_3x0.html 3  
1 MAIN DOCUMENT DESCRIPTION c05448_3x0.xml 3 3741
  Complete submission text file 0001209191-10-044431.txt   5740
Mailing Address 300 GEORGE STREET NEW HAVEN CT 06511
Business Address 300 GEORGE STREET NEW HAVEN CT 06511 203-624-7000
ACHILLION PHARMACEUTICALS INC (Issuer) CIK: 0001070336 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104
Business Address QUAKER BIOVENTURES 2929 ARCH STREET PHILADELPHIA PA 19104 (215) 988-6800
Quaker BioVentures II LP (Reporting) CIK: 0001497725 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-33095 | Film No.: 101047204